Open AccessTreatment of Hypoactive Sexual Desire Disorder Among Women: General Considerations and Pharmacological Options
Author(s) -
Gabriela S. Pachano Pesantez,
Anita H. Clayton
Publication year - 2021
Publication title -
focus/focus (american psychiatric publishing. online)
Language(s) - English
Resource type - Journals
eISSN - 1541-4108
pISSN - 1541-4094
DOI - 10.1176/appi.focus.20200039
Subject(s) - hypoactive sexual desire disorder , personal distress , context (archaeology) , distress , psychiatry , psychotherapist , depression (economics) , sexual desire , psychology , medicine , interpersonal communication , clinical psychology , human sexuality , social psychology , gender studies , paleontology , macroeconomics , sociology , economics , biology
Hypoactive sexual desire disorder (HSDD) is a persistent or recurrent absence of sexual fantasies and desire for sexual activity, causing marked personal distress or interpersonal difficulties. HSDD affects 10% of U.S. women and is associated with depression and other negative emotional states. It is imperative that psychiatrists are competent to make this diagnosis and are aware of available treatment options. A full psychiatric and medical history are necessary to identify potential causes or contributing factors that may need to be addressed first. The authors discuss the diagnostic tools available as well as general diagnostic considerations for psychiatrists. Given its importance in the understanding of the available treatments for this disorder, the pathophysiology behind HSDD is reviewed. The authors emphasize the treatment of HSDD, including general treatment considerations, treatment in the context of depression, and psychotherapy and medications that have been approved by the U.S. Food and Drug Administration.